Company / Working Capital per Share
Zenas BioPharma, Inc. Working Capital per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.90
FY2025
5-year range
$6.90 / $189.38
FY2023-FY2025
Trend
-96.4%
vs FY2024
Sector context
#77 of 210
Health Care
What the data says
At $6.90, Zenas BioPharma, Inc.'s working capital per share ranks #77 of 210 in the Health Care sector. Declined from $23.87 to $6.90 over the past 2 years.
Based on SEC 10-K filings.
6.90 in FY2025.
Declined from $23.87 to $6.90 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#77 of 210 in Health CareTop 37% of 210This company $6.90 Sector average $146.86
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 96.4% year-over-year.
- Ranks #77 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.90 | -96.4% |
| FY2024 | $189.38 | +693.5% |
| FY2023 | $23.87 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026